Studying the roles of RhoA and Anillin in C. elegans epidermal morphogenesis. by Fotopoulos, Nellie
38 
 
Chapter 3. Results 
3.1. rho-1 regulates epidermal elongation in C. elegans embryogenesis 
3.1.1 Zygotic rho-1 is required for elongation 
Elongation is driven by actin-myosin contraction in the seam cells, which changes 
their shape from cuboidal to cylindrical and causes a 4-fold increase in the length of the 
embryo (Chisholm and Hardin, 2005). These contractions are controlled by Rho 
kinase/LET-502, which is highly expressed in the seam cells and is required for 
nonmuscle light chain phosphorylation (Wissmann et al., 1997; Piekny et al., 2000; 
Piekny and Mains, 2002). In higher eukaryotes, Rho kinase is a downstream effector of 
active RhoA, and we hypothesize that C. elegans RhoA/RHO-1 also has a role in 
elongation.  In support of this, embryos mutant for rga-2, which encodes a GAP (GTPase 
activating protein) for RHO-1, show elongation phenotypes similar to mel-11 (myosin 
phosphatase regulatory subunit) mutants, where embryos rupture likely due to 
hypercontractility (Diogon et al., 2007). A function for rho-1 in elongation had not been 
determined due to its maternal requirement for cytokinesis and the lack of zygotic alleles. 
Recently, a deletion allele of rho-1, ok2418, was generated by the Knockout Consortium, 
and consists of a 2091bp deletion that removes aas 53-192. The remaining portion of the 
protein (1-52 amino acids) is considered null, as it would not be able to function 
biochemically (Dvorsky and Ahmadian, 2004). This allele was used to determine if rho-1 
is required for elongation and to ascertain rho-1’s placement in the pathway. 
First, we assessed the phenotype of rho-1 (ok2418) homozygous embryos. 
Embryos from hermaphrodites heterozygous for rho-1 (over a wild type chromosome or 
mutant for dpy-4) segregated 76% wt or Dpy worms and the homozygous rho-1 mutant 
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embryos were lethal (15.1%) or arrested as Lpy Dpy larvae (8.9%; Table 1).  Live 
imaging was performed with embryos from rho-1/dpy-4 heterozygous hermaphrodites to 
obtain a better assessment of their phenotypes. Approximately 20% of the progeny (rho-1 
homozygous embryos, n≥300) arrested at the 1.5-2-fold stage of elongation during 
embryogenesis (Figure 11). Some of these embryos hatched the next day and arrested as 
Lpy Dpy larvae. A 1.5-2-fold arrest is commonly observed with mutations in genes that 
regulate embryonic elongation, but can also arise from mutations in genes that form 
muscle or muscle attachments (e.g. pats – paralyzed at two-fold; Zhang and Labouesse, 
2010; Zhang et al., 2010).  
To better assess the rho-1 phenotype, mutant embryos were filmed using a marker 
for the adherens junctions of epidermal cells. A strain heterozygous for the rho-1 
(ok2418) allele and expressing AJM-1::GFP (adherens junction marker) was generated 
and embryos from these worms were imaged using fluorescence microscopy (performed 
by Y. Chen). AJM-1 is found at cell-cell junctions and serves as a good tool to observe 
cell shape changes as it outlines the epidermal cells. AJM-1 localization in homozygous 
rho-1 (ok2418) embryos resembled wild-type embryos during early stages of elongation 
(comma-1.5-fold stage), but the rho-1 homozygous embryos did not elongate past the 2-
fold stage and the shape of the seam cells did not fully change into long cylindrical 
shapes (by Y. Chen; Figure 12). This result suggests that the epidermal cells are born and 
adhere properly in rho-1 mutant embryos, but the lateral epidermal cells are not able to 
extend beyond a certain length. 
 
3.1.2. RHO-1 localizes to the boundaries of epidermal cells 
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N2 (wt) 20 100 0 0 
rho-1(ok2418)/dpy-4(e1166) 20 84.9 15.1 8.9 
mlc-4(or253)/qC1 20 94.4 5.6 24.2 
mlc-4(or253)/+;rho-1(ok2418)/+ 20 82.7 17.3 20.8 
let-502(sb118ts) 20 95.2 4.8 0 
let-502(sb118ts)/+;rho-1(ok2418)/+ 20 82.2 17.8 7.8 
let-502(sb118ts);rho-1(ok2418)/+ 20 Sterile: low brood size 
mel-11(it26ts) 15 20 80 0 
mel-11(it26ts) 20 8.8 91.2 0 
mel-11(it26ts) 25 0 100 0 
mel-11(it26ts); 
rho-1(ok2418)/+ or rho-1(ok2418) 
15 31 69 2 
mel-11(it26ts); 
rho-1(ok2418)/+ or rho-1(ok2418) 
20 15.6 84.4 0 
mel-11(it26ts); 
rho-1(ok2418)/+ or rho-1(ok2418) 
25 Sterile: low brood size 
rhgf-2(sb100) 20 99.9 0.01 0 
rhgf-2(sb100)/+; rho-1(ok2481)/+ 20 75.7 24.3 6.7 
rhgf-2(sb100); rho-1(ok2481) 20 73 27 11 
 
n > 300 embryos and larva per cross except for rhgf-2(sb100); rho-1(ok2481), n = 167 
(performed with Y. Chen). 
* Embryonic lethality includes embryos arrested at different stages. 
 





Figure 11. rho-1 is required for elongation. DIC images from time lapse movies of N2, 
rho-1 (ok2418), let-502 (sb118) and let-502(sb118); rho-1 (ok2418) embryos from 
comma stage (just after ventral enclosure has completed) to past the 3-fold stage of 

















Figure 12. rho-1 is required for epidermal cell shape changes during elongation. 
Fluorescent images from time lapse movies of AJM-1::GFP and rho-1 (ok2418);AJM-
1::GFP embryos from early elongation (1.2-fold stage) to just past the 3-fold stage of 















If rho-1 is genetically required for elongation, then it should be enriched in the 
lateral epidermal cells. Unfortunately there are no anti-RHO-1 antibodies that work for 
immunofluroescence, nor is there a GFP::RHO-1 transgenic strain containing the rho-1 
promoter. However, there is a GFP::RHO-1 strain that is controlled by the maternal 
promoter for pie-1. The pie-1 gene is maternally expressed and is required for 
establishing cell fates in the early embryo (Curran et al. 2009). Although it is not well 
understood why, the pie-1 promoter permits germline expression, while many other 
promoters are repressed. Therefore, using the pie-1 promoter enables the visualization of 
proteins of interest. GFP::RHO-1 localized to the boundaries of all epidermal cells during 
dorsal intercalation, ventral enclosure, and elongation (Figure 13). This result suggests 
that maternal RHO-1 is very stable and persists through the early stages of elongation.  
 
3.1.3. rho-1 is part of the elongation pathway 
The phenotype of rho-1 homozygous embryos supports its requirement for 
elongation, likely as a regulator of myosin contractility. To place rho-1 in this pathway, 
crosses were performed with strains carrying mutations in genes of the elongation 
pathway, and hatching rates and/or % of larval Lpy Dpy phenotypes were determined. 
The interaction between two genes was considered to be enhanced if the observed 
lethality for the double mutant exceeded predicted additive lethality rates for each mutant 
on its own, as determined by the Chi-square analysis (p > 0.05). More specifically, the 
rho-1 allele, ok2418, was crossed with mutations in mlc-4 (nonmuscle myosin regulatory 
light chain), let-502 (Rho kinase), mel-11 (myosin phosphatase regulatory subunit) and 






Figure 13. rho-1 localizes to epidermal cell boundaries. Fluorescent images from time 
lapse movies of GFP::RHO-1 embryos show GFP::RHO-1 localization at the boundaries 
of epidermal cells during dorsal intercalation, ventral enclosure and elongation as 










and rho-1 (ok2418) segregated progeny with phenotypes that matched the predicted 
frequencies for each allele (Table 1). The lack of enhancement between the null alleles 
supports that mlc-4 (nonmuscle myosin regulatory light chain) and rho-1 (Rho kinase) 
function in the same pathway.  
Crosses were also performed to determine if rho-1 and let-502 genetically 
interact. The let-502 allele, sb118, is a hypomorphic temperature sensitive (ts) allele with 
high viability at 20°C (95%). Hermaphrodites heterozygous for both alleles segregated 
progeny with phenotypes that matched the predicted frequencies for each allele, 
suggesting that rho-1 and let-502 function in the same pathway (Table 1). Live imaging 
of let-502 (sb118); rho-1 (ok2418) embryos revealed elongation phenotypes similar to 
severe let-502 (sb118) embryos (Figure 11). Also, let-502 (sb118); rho-1 (ok2418)/+ 
hermaphrodites had low brood sizes (Table 1; performed together with Y. Chen). This 
enhancement could suggest that rho-1 has some haploinsufficiency, which is only 
revealed when it is in combination with a partial loss of maternal let-502.  
To further assess rho-1’s placement in the elongation pathway, the rho-1 mutant 
was crossed with a mutation in mel-11 (myosin phosphatase regulatory subunit). mel-11 
(it26) is a ts allele that shows embryonic lethal phenotypes at 15
 o
C (20% hatching) and 
20
 o
C (2% hatching), due to rupturing of the embryo during elongation likely because of 
increased contractility in the epidermal cells. Embryonic lethality of mel-11 (it26) was 
partially suppressed by rho-1 (ok2418) (or rho-1 (ok2418)/+) at 15
 o
C (31% hatching) 
and 20
 o
C (16% hatching; Table 1; performed together with Y. Chen). In addition, a small 
number of embryos displayed larval Lpy Dpy phenotypes and 2-fold arrest, similar to the 
rho-1 phenotype. Although the mel-11 allele is not null, this result suggests that rho-1 
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and mel-11 function antagonistically and rho-1 is epistatic to mel-11. As an upstream 
regulator of Rho kinase and myosin contractility, reducing rho-1 function could alleviate 
the hypercontractility caused by the removal of myosin phosphatase. 
Lastly, rho-1 was tested for genetic interactions with a hypomorphic allele of 
rhgf-2, which encodes a GEF for RHO-1 (Lin et al. 2012). The hatching rates were 
slightly lower for the double mutants in comparison to each mutant on its own, 
supporting weak enhancement between rho-1 and rhgf-2 (Table 1; performed with Y. 
Chen). It is not clear why there is some enhancement between rho-1 and rhgf-2, which 
could occur if RHGF-2 also functions in a parallel pathway. However, the potential 
overlapping requirement for both maternal and zygotic rho-1 during elongation could 
also explain the enhancement. Live imaging revealed that the elongation defects of the 
rhgf-2 (sb100); rho-1 (ok2481) embryos (data not shown) were similar to rho-1 (ok2418) 
embryos, as expected if rhgf-2 is an upstream activator of rho-1.  
Together, these data support a role for rho-1 in elongation. The two-fold arrest 
phenotype that arises from the zygotic null allele, coupled with its genetic interactions 
with various components of the elongation pathway indicates that RHO-1 is an upstream 
regulator of myosin contractility. 
 
3.2. ani-1 is non-autonomously required for ventral enclosure during C. elegans 
embryogenesis 
3.2.1 ani-1 is required throughout embryogenesis  
ANI-1 shares homology with human anillin, which has binding sites for both F-
actin and active myosin, and is hypothesized to organize actin-myosin contractility in the 
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early embryo (Maddox et al., 2007; Tse et al., 2011). Elongation also requires actin-
myosin contractility within the lateral epidermal cells to drive their shape change. In 
addition, other events in epidermal morphogenesis, including dorsal intercalation and 
ventral enclosure may also require actin-myosin contractility for cell migration and shape 
changes.  
To determine if ani-1 is required for epidermal morphogenetic events during 
embryogenesis, N2 hermaphrodites were treated with ani-1 RNAi. Depletion of ani-1 
gave 43% embryonic lethality and 13.4% larval Lpy Dpy phenotypes (Table 2). The Lpy 
Dpy phenotype signifies abnormal body morphology and presumably arises due to 
defects in epidermal morphogenesis. To better assess the embryonic phenotypes, ani-1 
RNAi embryos were imaged throughout development. A large percentage (51.6%, 
normalized from lethal embryos) of embryos displayed early phenotypes (amorphous ball 
of cells with no obvious structures), likely due to failed polar body extrusion or 
cytokinesis defects (Maddox et al., 2007; Dorn et al., 2010). However, the remaining 
embryos displayed defects later in development, including ventral enclosure and 
elongation (Figure 14). The range from early to late phenotypes supports that ani-1 is 
required throughout embryogenesis, and this data supports that it may regulate epidermal 
morphogenesis. 
 Since ani-1 is required maternally for polar body extrusion (Dorn et al., 2010) and 
cytokinesis (Maddox et al., 2005; Maddox et al., 2007), we wanted to bypass these early 
requirements and study the zygotic-specific function of ani-1. To test for this, rde-1 
(RNAi-resistant) hermaphrodites were treated with ani-1 RNAi and outcrossed to N2 












































Data was averaged from four experiments, with 4-9 hermaphrodites per experiment, and 
n > 300 for ani-1 RNAi and n > 100 embryos and larva for rde-1 treatments and crosses. 


















Figure 14. ani-1 is required throughout embryogenesis. DIC images from time lapse 
movies of N2 and ani-1 RNAi embryos are shown in the top two sets of panels as 
indicated. The movies start from ventral enclosure and continue past the 3-fold stage of 
elongation. rde-1 (ne219) hermaphrodites were treated with L4440 (vector alone control) 
or ani-1 RNAi and outcrossed to N2 males. DIC images from time lapse movies of 














mother, but zygotically expressed ani-1 was susceptible to knockdown by RNAi. A range 
of 4 to 9 Lpy Dpy larva were observed on each of the mated plates, giving a total of 
17.6% Lpy Dpy larva (the average brood size per plate was ~35 embryos and only first 
broods were considered as the RNAi was titrated out in younger oocytes; Table 2). This 
percentage of Lpy Dpy larva is consistent with what was observed for ani-1 RNAi, and 
may reflect zygotic-specific requirements for ani-1 in epidermal morphogenesis. In 
support of this, embryos imaged by DIC displayed ventral enclosure and elongation 
phenotypes consistent with what was observed with ani-1 RNAi (Figure 14). These 
results indicate that ani-1 is required throughout embryogenesis, and is both maternally 
and zygotically required for epidermal morphogenesis. 
 
3.2.2. ani-1 is required for ventral enclosure 
Initial phenotyping of ani-1 RNAi embryos revealed defects in epidermal 
morphogenesis. To better characterize ani-1’s role in this process, live imaging was 
performed using embryos from AJM-1::GFP hermaphrodites treated with ani-1 RNAi. 
As described earlier, AJM-1 marks epidermal cell boundaries, permitting the 
visualization of all stages of epidermal morphogenesis. Of the ani-1 RNAi embryos that 
did not arrest early, 33% displayed ventral enclosure defects where the ventral cells failed 
to properly migrate and adhere at the ventral midline (vs. 3% of AJM-1::GFP on L4440, 
n = 79; Table 3 and Figure 15). For this data set, embryos were considered to have an 
‘early’ ventral enclosure phenotype if the leading edge cells and/or posterior pocket cells 
failed to meet at the ventral midline (ventral epidermal cells always migrated to some 
degree and were not truly ‘early’, which is when epidermal cells fail to migrate altogether 
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Table 3. ani-1 is required during ventral enclosure. 
 
Genotype % VE phenotypes % WT 
AJM-1::GFP; L4440 3 97 
AJM-1::GFP; ani-1 RNAi 33 67 
 
n > 79 
% phenotypes were normalized (e.g. early phenotypes not counted) to reflect the 































Figure 15.  ani-1 is required for ventral enclosure. Inverted fluorescent images from 
time lapse movies of control and AJM-1::GFP; ani-1 RNAi embryos showing the 
migration of ventral epidermal cells during ventral enclosure. Z-stack projections of 

















and remain on the dorsal surface; Figure 15). A ‘late’ ventral enclosure phenotype was 
when the ventral epidermal cells met at the ventral midline (resembling wild-type 
embryos), but failed to properly seal causing internal contents to extrude later in 
development (data not shown). There was an equal ratio of embryos among the early and 
late ventral enclosure phenotypes, suggesting that ani-1 is required for the proper 
migration and/or adhesion of ventral epidermal cells (Table 4). This data also suggests 
that the larva Lpy Dpy phenotypes may reflect weak ventral enclosure phenotypes, 
similar to mutations in other genes that regulate cell adhesion such as hmr-1 (cadherin), 
hmp-1 (alpha-catenin) and hmp-2 (beta-catenin; Costa et al., 1998). To ascertain if the 
ventral enclosure defects were a consequence of earlier defects, dorsal intercalation was 
visualized in ani-1 RNAi embryos. Dorsal intercalation in ani-1 RNAi embryos was 
similar to control embryos, suggesting that ani-1 is not required for earlier morphogenetic 
events (Table 4).  
 
3.2.3 ani-1 functions in parallel to the rho-1 pathway 
ani-1 may be required for ventral enclosure, but it is not clear how ani-1 could 
regulate ventral epidermal cell migration or adhesion. Anillin is a regulator of actin-
myosin contractility, suggesting that active myosin also may contribute to ventral 
enclosure. To determine if the rho-1 pathway affects the lethality caused by ani-1 RNAi, 
strains carrying mutations in genes known to regulate myosin contractility (rho-1, mlc-4, 
let-502, mel-11, nmy-1, rhgf-2 and let-502; mel-11) were treated with ani-1 RNAi, and 
monitored for embryonic lethality. The interaction between two genes was considered to 
be enhanced if the observed lethality exceeded predicted additive lethality rates, as  
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0 0 0 
AJM-1::GFP/HMR-
1::GFP; ani-1 RNAi 
(n=19) 
0 10 9 
 
‘Early’ defects are when the ventral epidermal cells fail to meet at the midline and fail to 
adhere. 
‘Late’ defects are when the ventral epidermal cells meet at the midline and appear to 
close, but show defects later in development (e.g. late rupture or larval Lpy Dpy; 















determined by Chi-square analysis (p < 0.05). All of the mutant strains treated with ani-1 
RNAi showed enhanced embryonic lethality (Table 5 and Appendix 1). For example, 
rho-1 (ok2418)/dpy-4; ani-1 RNAi displayed hatching rates of 13.9% vs. 73.4% for rho-1 
(ok2418)/dpy-4; L4440 and 53.2% for ani-1 RNAi, and the expected additive hatching 
rates were 26.6% (combined lethality; same logic applies to the rest of the RNAi 
experiments; Table 5 and Appendix 1). 
Since ani-1 RNAi sensitizes the early embryo for cytokinesis defects in 
combination with depletion of myosin and/or its regulators (Maddox et al., 2007), this 
could explain the enhancement between ani-1 and rho-1 or mlc-4. However, 
enhancement also was observed between ani-1 RNAi and mutations in nmy-1 and rhgf-2, 
genes that are zygotically required for elongation (Table 5 and Appendix 1). Mutations in 
these genes do no cause cytokinesis defects and the enhanced lethality with ani-1 could 
arise from events during later stages of embryogenesis. Since let-502 and mel-11 are 
required both maternally for cytokinesis and maternally and zygotically for elongation, 
the enhanced lethality of let-502 and mel-11 could be due to increased cytokinetic defects 
or increased morphogenetic defects (Table 5 and Appendix 1). Enhancement of the 
double mutant, let-502 (sb118); mel-11 (it26ts), suggests that ani-1 functions in parallel 
to the let-502/mel-11 pathway for myosin contractility or ani-1 regulates a different 
process altogether (e.g. stabilizing F-actin; Table 5 and Appendix 1).  
 
3.2.4. ani-1 depletion does not cause cytokinetic defects in epidermal cells 
 Since ani-1 is maternally required for actin-myosin contractile events in the early 
embryo including cytokinesis, it is possible that ani-1’s ventral enclosure phenotypes  
56 
 















rho-1(ok2418)/+ 20 53.2 
 
73.4 13.9 Enhancement 
 
mlc-4(or253)/qC1 20 60.8 
 
95.1 44 Enhancement 
 































































n > 300 per cross 
* Significance tested by Chi-square analysis; rho-1 (p<0.05); mlc-4 (p<0.05); mel-11 
(p<0.05); nmy-1 (p<0.01); let-502 (p<0.05); rhgf-2 I (p<0.05); let-502;mel-11 (p<0.01). 











arise from cytokinesis defects in the epidermal cells. Interestingly, dorsal intercalation 
and ventral enclosure can still occur in embryos with fewer epidermal cells, although they 
show mild ventral enclosure phenotypes (Hardin et al., 2008). To determine if the ventral 
enclosure defects in ani-1 RNAi embryos are from cytokinetic defects, the number of 
epidermal cells was counted in control and ani-1 RNAi embryos. Control embryos should 
have 20 dorsal, 20 ventral and 20 seam cells. There were some difficulties in obtaining 
3D projections that perfectly outlined every cell, and an average of 16 dorsal, 19 ventral 
cells, and 20 seam cells were counted for control AJM-1::GFP embryos. AJM-1::GFP; 
ani-1 RNAi embryos that displayed ventral enclosure phenotypes had similar numbers of 
epidermal cells (19 dorsal, 19 ventral and 20 seam) vs. control embryos (performed with 
D. Wernike; Table 6). Therefore, the ventral enclosure phenotypes in ani-1 depleted 
embryos likely are not due to cytokinetic defects in the epidermal cells. 
 
3.2.5 ANI-1 is highly expressed in neuroblasts 
ANI-1’s localization was determined during mid-late embryogenesis to determine 
if it is consistent with its role in ventral enclosure. ANI-1::GFP (driven by the pie-1 
promoter), localizes to the contractile ring and cortex in the early embryo (Maddox et al., 
2007). ANI-1 continues to localize to the contractile ring and cortex of dividing cells 
through the first half of embryogenesis, tapering off before dorsal intercalation (data not 
shown). Since the maternally-driven ANI-1 construct does not show zygotic expression, 
embryos of various stages were fixed and stained with ANI-1 antibodies. Similar to the 
GFP probe, antibodies revealed strong ANI-1 localization at contractile rings and cell 
boundaries in the early embryo (Figure 16). However, unlike the GFP probe, ANI-1 was  
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16 ± 2 19 ± 1 20 ± 1  
AJM-1::GFP or HMR-
1::GFP; ani-1 RNAi 
 
19 ± 1 
 
19 ± 1 
 
20 ± 1 
 
Control (AJM-1::GFP or HMR-1::GFP) n = 21 for dorsal cells, n = 17 for ventral cells 
and n = 14 for seam cells 
ani-1 RNAi (AJM-1::GFP or HMR-1::GFP) n = 20 for dorsal cells, n = 17 for ventral 
cells and n = 10 for seam cells 
Embryos displaying ventral enclosure phenotypes (and not earlier) were counted 























Figure 16. ANI-1 localizes to cell boundaries and contractile rings of dividing cells 
during embryogenesis. Z-stack projections of fluorescent images of immunostained N2 
embryos showing ANI-1 localization at cleavage furrows and cell boundaries in an early 
embryo (panels on top). ANI-1 appears to localize in dividing neuroblasts during ventral 
enclosure. Shown are DIC, DAPI (for DNA), Tubulin and ANI-1 images. Merged images 
with Tubulin in red and ANI-1 in green are also shown. The arrow points to cell 















enriched in dividing cells underneath the epidermis, likely neuroblasts (Figure 16). 
Confocal images of AJM-1::GFP embryos co-stained for GFP and ANI-1 during ventral 
enclosure verified that ANI-1 does not localize within epidermal cells (based on z planes 
of 0.2 m thickness; Figure 17). Therefore, although ani-1 depletion causes ventral 
enclosure phenotypes, ANI-1 is not expressed in ventral epidermal cells suggesting that 
ani-1 functions in a non-autonomous manner. Other genes that function in neuroblasts, 
such as vab-1 and vab-2, are also required for ventral enclosure likely because the 
neuroblasts act as a substrate for epidermal cell migration (Chin-Sang et al., 1999; Chin-
Sang et al., 2002). 
 To determine if ANI-1 is expressed in specific subsets of neuroblast cells, 
attempts were made to co-stain ANI-1 with VAB-1 and VAB-2/EFN-1. VAB-1 is 
expressed in anterior neuroblasts, while EFN-1 is expressed in cells in the middle of the 
embryo. Strains over-expressing VAB-1 or VAB-2 were fixed and stained with 
antibodies against ANI-1 and VAB-1 or VAB-2 (Courtesy of I. Chin-Sang, Queen’s 
University). Since all antibodies were generated in rabbits, goat anti-rabbit Fab fragments 
were used to change the identity of one of the antisera (e.g. ANI-1 or VAB-1 or VAB-2) 
to goat. However, tests with control embryos revealed that the Fab fragments could not 
convert 100% of the ANI-1 antisera to goat, making it difficult to properly co-stain ANI-
1 with VAB-1 or VAB-2. Studies are currently underway to co-stain ANI-1 in embryos 
expressing other markers for neuroblast cells. 
 





Figure 17. ANI-1 is expressed in the neuroblasts underlying the ventral epidermal 
cells. Confocal images show the localization of ANI-1 and AJM-1 during late ventral 
enclosure in AJM-1::GFP-expressing, fixed embryos. ANI-1 (red) appears to localize to 
the underlying neuroblasts as opposed to the epidermal cells, which are outlined in green. 
















ani-1 may be required non-autonomously in the neuroblasts to regulate ventral enclosure. 
To test ani-1’s requirement in the epidermal cells, a mosaic analysis was performed using 
RNAi-resistant worms carrying rescue constructs under the control of an epidermal cell-
specific promoter or a muscle cell-specific promoter (as a control). The rde-1 (nr222) 
strain is ‘rescued’ with a wild-type allele in the epidermal cells, making only this tissue 
permeable to RNAi treatments. Therefore, any phenotypes that arise after RNAi support a 
requirement for that gene in epidermal cells. As a control, rde-1 (nr350) was used, which 
is ‘rescued’ with a wild-type allele in muscle tissue. Any gene that is required in the 
epidermal cells, but not in the muscle tissue should only show lethality with the nr222 
allele, but not with the nr350 allele after RNAi. To test the strains, both were treated with 
rho-1 RNAi, which is known to function in the epidermal cells, but not in the muscle. 
Typically, rho-1 RNAi is used a control for testing the efficacy of RNAi since it quickly 
depletes endogenous rho-1 in N2 embryos, and shows 100% lethality within 24 hours. 
Unfortunately, both strains showed 100% hatching, suggesting a problem with the nr222 
strain. Therefore, ani-1 was not tested using these strains. Current studies will attempt to 
perform rescue experiments by expressing ani-1 under the control of tissue-specific 
promoters (to be performed by D. Wernike).  
 
3.2.7 Myosin Contractility May Influence Ventral Enclosure 
ani-1 functions non-autonomously to regulate ventral enclosure, and is expressed 
in dividing neuroblasts. It is not clear how the neuroblasts regulate the migration of the 
overlying ventral epidermal cells. Previous studies suggest that ephrin and semaphorin 
signaling pathways could provide chemical guidance cues, but there are other pathways 
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and/or mechanisms that remain to be determined (Ghenea et al. 2005; Ikegami et al. 
2012). We hypothesize that ani-1 could be required for the division and/or stiffness of 
neuroblasts, which could alter their ability to regulate epidermal cell migration in a 
mechanical manner. To help test this, myosin contractility was altered in the epidermal 
cells to determine how they influence the ventral enclosure phenotypes caused by ani-1 
RNAi. Embryos with different contractile backgrounds (let-502 (sb118), mel-11 (it26) 
and nmy-1 (sb115)) were treated with ani-1 RNAi and imaged by time lapse. Embryos 
were placed into several categories based on their mutant phenotypes. ‘Early’ describes 
embryos that did not reach ventral enclosure, ‘early rupture’ are embryos that failed 
ventral enclosure and ruptured prior to undergoing extensive elongation (until the 1.5-
fold stage), ‘late rupture’ are embryos that ruptured during elongation (after the 1.5-fold 
stage) and ‘elongation’ phenotypes describe embryos that did not rupture, but failed to 
complete elongation (Table 7). The majority of ani-1 RNAi embryos arrested early 
(likely due to meiotic and cytokinesis defects), with a relatively even distribution of 
embryos in the remaining categories (Table 7). let-502 (sb118); ani-1 RNAi embryos had 
an increased number of early and elongation phenotypes and a decrease in the proportion 
of ventral enclosure defects vs. ani-1 RNAi (Table 7 and Figure 18). The enhanced 
percentage of early phenotypes likely reflects let-502’s maternal requirement for 
cytokinesis, while the enhanced elongation phenotypes reflects let-502’s maternal and 
zygotic requirement for elongation. The decrease in ventral enclosure phenotypes could 
be explained by weakened pressure on the embryo from decreased myosin contractility in 
















N2 (wt) 0 0 0 0 
ani-1 RNAi 51.6 22.6 9.7 16.1 
let-502(sb118ts) 52.2 - - 47.8 
let-502(sb118ts); ani-1 RNAi 65.9 7.3          -            26.8 
nmy-1(sb115)  10.1 - - 89.9 
nmy-1(sb115); ani-1 RNAi 38.7 11.5 38.7 11.5 
mel-11(it26ts)  8.3 8.3 83.3 - 
mel-11(it26ts); ani-1 RNAi 41.2 58.8 - - 
 
n ≥30 embryos, except for mel-11(it26ts); ani-1 RNAi where n=15 
*Early VE (ventral enclosure) rupture is defined as ventral enclosure rupture up to and 
including the 1.5-fold stage of elongation, and late VE rupture is defined as rupture after 
the 1.5-fold stage of elongation.  
**Elongation phenotypes include embryos arrested at different stages of elongation 












Figure 18. ani-1’s ventral enclosure phenotypes are enhanced or suppressed by 
regulators of myosin contractility. DIC images from time lapse movies of N2, ani-1 
RNAi, let-502 (sb118), let-502 (sb118); ani-1 RNAi, nmy-1 (sb115), nmy-1 (sb115); ani-
1 RNAi, mel-11 (it26) and mel-11 (it26); ani-1 RNAi from ventral enclosure to past the 
3-fold stage of elongation. All imaging was done at room temperature (22°C). Scale bar 







increase in late rupture phenotypes vs. ani-1 RNAi (Table 7 and Figure 18). Since nmy-1 
is partially redundant with nmy-2 for elongation (Piekny et al., 2003), these embryos 
likely have more contractility in their epidermal cells and thus more pressure may be 
exerted from these cells in comparison to let-502 mutants, but not as much as wild-type 
embryos. Lastly, mel-11 embryos tend to rupture during elongation, likely due to 
hypercontracting epidermal cells, which exert too much pressure on the internal contents 
of the embryo. The shift to early rupture phenotypes after ani-1 depletion suggests that 
these embryos are sensitized to pressure changes (Table 7 and Figure 18). These data 















Chapter 4. Discussion 
 The epidermis of the developing C. elegans embryo undergoes several 
morphogenetic events including ventral enclosure to enclose the embryo in a layer of 
epidermal tissue, and elongation to increase the length of the embryo up to 4-fold. 
Elongation occurs due to actomyosin-mediated cell shape changes, yet the upstream 
regulator RhoA had not been shown to be required for this event. Ventral enclosure also 
requires changes in the actin cytoskeleton to drive migration and cell adhesion. Migration 
of the ventral epidermal cells is non-autonomously regulated by neuroblasts, however, 
the mechanism(s) by which they do this is poorly understood. Identifying novel 
regulators of epidermal morphogenesis in C. elegans can shed light on how metazoan 
tissues form in vivo. My thesis confirms that C. elegans RhoA (rho-1) as an upstream 
regulator of elongation and describes a novel non-autonomous role for C. elegans anillin 
(ani-1) in ventral enclosure.  
 
4.1 rho-1 is required for elongation 
Elongation occurs due to the concerted activity of Rho-dependent kinase (LET-
502), which positively regulates nonmuscle myosin activity and myosin phosphatase 
regulatory subunit (MEL-11), which down regulates myosin activity via myosin 
phosphatase. High levels of LET-502 in the lateral epidermal cells drive elongation, 
while high levels of MEL-11 in the dorsal and ventral cells ensure they follow passively 
(Wissmann et al. 1997; Piekny et al., 2000). Since LET-502 is a predicted effector for 
RHO-1, it is likely that rho-1 also is required for elongation, yet until recently there were 
no rho-1 alleles (Wissmann et al. 1997; Piekny et al. 2000; Diogon et al., 2007). Using a 
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zygotic null allele created by the Knockout Consortium, I found that rho-1 is required for 
elongation. The rho-1 phenotype, two-fold arrest, is slightly later vs. strong let-502 
alleles, which cause arrest at the comma to1.5-fold stage. rho-1 may be required both 
maternally and zygotically, similar to let-502, and the shift to later phenotypes reflects 
the maternal vs. zygotic contribution of rho-1 to elongation. In support of this, RHO-
1::GFP, which is driven by the maternal promoter pie-1, localizes to epidermal cell 
boundaries throughout elongation. This suggests that maternal RHO-1 is very stable, and 
may be sufficient to drive early elongation, but the embryo needs a boost of zygotic 
expression to complete elongation.  
rho-1 functions in the elongation pathway based on its genetic interactions with 
components of the pathway that regulate nonmuscle myosin activity, including mlc-4 
(nonmuscle myosin regulatory light chain), let-502 (Rho kinase), mel-11 (myosin 
phosphatase regulatory subunit) and rhgf-2 (RhoGEF). There was no genetic interaction 
between zygotic null alleles for both rho-1 and mlc-4, suggesting that they function in the 
same pathway. However, embryos (or lack thereof) from let-502 (sb118); rho-1 /+ 
hermaphrodites showed enhancement, which could be due to the decreased levels of 
maternal rho-1 in these embryos. Elongation requires both maternal and zygotic let-502 
(Piekny et al., 2000) and similarly both maternal and zygotic rho-1 could be required for 
elongation (and other contractile events). This makes the interpretation of genetic crosses 
using hypomorphic let-502 alleles complicated. Moreover, ovulation and germ cell 
proliferation depend on let-502, so lowering its levels of could disrupt and/or sensitize 
these processes within the hermaphrodite. Further support for rho-1 in the elongation 
pathway is from the suppression of mel-11 embryonic lethality by the rho-1 mutant. 
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Mutations in let-502 and mel-11 dominantly suppress one another and an upstream 
regulator of let-502 should similarly suppress mel-11. Removal of MEL-11 (a negative 
regulator of nonmuscle myosin) causes epidermal cells to hypercontract, and removing 
RHO-1 (a positive regulator of contraction via LET-502) likely alleviates the 
hypercontraction. Furthermore, although the number was low, some embryos hatched and 
displayed rho-1 phenotypes (larval Lpy Dpy), which is expected if rho-1 is an essential 
gene. Therefore, unlike let-502, rho-1 is essential for elongation and could regulate 
additional proteins. 
RHGF-2 is the predicted RhoGEF and activator of RHO-1 during elongation (Lin 
et al. 2012). The weak enhancement observed between alleles of rhgf-2 and rho-1 
suggests that they function in separate pathways. However, strong enhancement between 
rhgf-2 and fem-2 (functions in a parallel pathway to let-502/mel-11) implies that rhgf-2 
and let-502 function in the same pathway (P.E. Mains, personal communication). 
Furthermore, the phenotype of the double mutant is the same as each on its own, 
supporting that they regulate the same process. Taking these findings into account, we 
hypothesize that rho-1 and rhgf-2 function in the same pathway. 
 
4.2 ani-1 is non-autonomously required for ventral enclosure during C. elegans 
embryonic development 
Anillin is a scaffold for actin and myosin, and helps organize actin-myosin 
contractility during cytokinesis and meiotic polar body extrusion (Maddox et al. 2005; 
Maddox et al. 2007; Dorn et al. 2010; Tse et al., 2011). Morphogenetic phenotypes were 
described for ani-1 RNAi in adult worms (Maddox et al. 2005), but additional embryonic 
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and/or larval phenotypes have not been reported. My data supports a role for ani-1 in 
ventral enclosure. Live imaging of AJM-1::GFP; ani-1 RNAi embryos revealed that 
although they appeared to have undergone dorsal intercalation properly, they displayed 
ventral enclosure phenotypes. Another regulator of cytokinesis, zen-4, causes 
morphogenetic defects, and these embryos had fewer epidermal cells vs. wt embryos. 
However, even with fewer cells, ventral epidermal cells migrated with similar dynamics 
to wt embryos, but adhesion was affected, likely due to uneven sealing at the midline 
(Hardin et al., 2008). This suggests that the ani-1 phenotypes are not simply a 
consequence of too few ventral epidermal cells. Indeed, co-staining fixed embryos 
undergoing ventral enclosure with ANI-1 antibodies and AJM-1 (adherens junction 
marker that outlines the boundary of epidermal cells) revealed that ANI-1 was not 
strongly expressed in the epidermal cells and confocal images imply that ANI-1 is 
expressed in the underlying neuroblast cells. Therefore, ani-1 may function non-
autonomously to regulate ventral enclosure. ANI-1 localized to cleavage furrows in the 
dividing neuroblasts, and remained at the boundaries of some cells, suggesting that ani-1 
could be required for their division, similar to cells in other metazoans (Piekny and 
Maddox, 2010). Since neuroblasts function as a substrate for the migrating ventral 
epidermal cells (George et al., 1998; Chin-Sang et al., 1999; Chin-Sang et al., 2002; 
Harrington et al., 2002), cytokinesis defects could alter their organization and stiffness, so 
that they no longer function as an effective substrate. 
Two categories of ventral enclosure phenotypes were observed in ani-1-depleted 
embryos. ‘Early’ describes the inability of ventral epidermal cells to reach the ventral 
midline, leaving a gap that ruptures by the comma stage. In embryos with the ‘late’ 
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phenotype, ventral epidermal cells reached the midline, but failed to adhere correctly and 
ruptured during elongation, or hatched, but displayed abnormal body morphologies (Lpy 
Dpy). As mentioned above, ANI-1 is zygotically expressed in dividing neuroblasts, 
suggesting that ani-1’s affect on ventral enclosure is non-autonomous. The relatively 
equal distribution of both early and late ventral enclosure phenotypes suggests that there 
could be different threshold requirements for ani-1 in neuroblasts. For example, strong 
depletion of ani-1 could cause neuroblast cytokinesis defects, and the decreased number 
of cells could impede the proper migration of ventral epidermal cells and cause the 
‘early’ phenotype. Weak depletion of ani-1 could still permit the appropriate number of 
neuroblasts to form, but could weaken their actin-myosin cytoskeleton and be less stiff of 
a substrate for the overlying epidermal cells. The migration of ventral epidermal cells 
could still occur, but may not adhere properly due to misalignment, causing the ‘late’ 
phenotype. Genes known to regulate adhesion, which include hmp-1 (alpha catenin), 
hmp-2 (beta catenin) and hmr-1 (e-cadherin), display abnormal body morphology 
phenotypes consistent with ‘late’ ani-1 phenotypes (Chisholm and Hardin, 2005). A 
recent study by Goldbach et al. (2010) showed that overexpression of E-cadherin in 
Drosophila spermatids suppresses cytokinesis defects in ani-1-depleted cells. A colleague 
of mine, Denise Wernike, investigated the potential genetic interactions between ani-1 
and adhesion genes and found that over-expression of α-catenin, hmp-1, can suppress the 
ani-1 phenotype and vice versa (i.e. over-expression of ani-1 can suppress loss of hmp-1). 
A possible explanation for this finding is that strengthening cell adhesion between 
neighboring cells at the ventral midline may make up for the loss of ani-1 and prevent 
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future rupturing. I propose a model where neuroblasts act as a substrate for the overlying 
ventral epidermal cells by providing mechanical support.   
Despite the observation that little ANI-1 was observed in the ventral epidermal 
cells by immunostaining, it is still possible that ani-1 is required in the ventral epidermal 
cells. Short, branched F-actin filaments mediate migration of the ventral cells via the 
activities of Rac (ced-10), Arp2/3 (arx-2/3), WAVE/SCAR regulators (gex-2 and gex-3) 
and WASP (wsp-1; Williams-Masson et al., 1997; Soto et al., 2002; Patel et al., 2008). 
However, there could be a role for long, unbranched F-actin and active myosin. In higher 
eukaryotes, migration often requires the combination of both systems, with the force- 
generating component coming from the contraction of stress fibres in the rear of the cell, 
which are adhered to underlying substrate. Another aspect of ventral enclosure is the 
closing of the ventral pocket, which is hypothesized to occur by a purse-string 
mechanism (Chisholm and Hardin, 2005). Presumably, this type of closure would require 
active myosin, and ani-1 could crosslink actin-myosin contractility to promote this event.  
 
4.3 Altering myosin contractility alters ventral enclosure defects in ani-1 RNAi 
embryos 
The non-autonomous regulation of epidermal tissue formation is not well 
understood. Previous studies showed that ephrin signaling is required for C. elegans 
ventral enclosure, and these components (e.g. VAB-1 and VAB-2) are expressed within 
neuroblasts (Chin-Sang et al. 1999). However, these studies also revealed that multiple 
mechanisms likely contribute to ventral enclosure, which are not known. My data 
revealed that ani-1, which encodes a scaffold for F-actin and active myosin, and regulates 
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actin-myosin contractility in the early embryo, is non-autonomously required for ventral 
enclosure. Since ANI-1 is expressed in the neuroblasts and could regulate their actin-
myosin cytoskeleton for cytokinesis or for cortical stiffness, I propose that neuroblasts 
could mechanically regulate the migration of overlying ventral epidermal cells. To help 
test this, we determined how changing cortical tension affected ani-1’s ventral enclosure 
phenotypes. Not surprisingly, enhancement of embryonic lethality was observed with all 
strains carrying mutations in components of the elongation pathway that regulate myosin 
contractility [rho-1, mlc-4, let-502, mel-11, rhgf-2 and nmy-1 (nonmuscle myosin heavy 
chain)]. Previous studies had shown that ani-1 RNAi sensitizes embryos to cytokinesis 
defects when combined with mutations in other contractile ring components including 
myosin (nmy-2 and mlc-4) and let-502 (Rho kinase; Maddox et al., 2005; Maddox et al., 
2007). However, imaging embryos that did not show these early phenotypes revealed 
shifts in ventral enclosure defects, depending on the elongation mutant. For example, 
mutations with decreased contractility e.g. in let-502, displayed a lower proportion of 
ventral enclosure defects after ani-1 RNAi. Mutations in nmy-1 display intermediate 
levels of contractility (it is partially redundant with nmy-2) and these embryos shifted to a 
higher proportion of late ventral enclosure defects after ani-1 RNAi. Mutations in mel-11 
likely cause hypercontractility and embryos shifted to a higher proportion of early ventral 
enclosure defects after ani-1 RNAi. These shifts in phenotypes reflect the roles of these 
genes in regulating myosin activity. Loss of LET-502 likely causes lower levels of 
myosin contractility and failed elongation due to lack of epidermal cell shape changes. 
This could decrease tension across cells and alleviate rupturing despite the inefficient 
migration or adhesion of ventral epidermal cells (Wissmann et al., 1997; Wissmann et al., 
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1999; Piekny et al., 2000; Piekny et al., 2003; Diogon et al., 2007; Gally et al., 2009). 
However, the suppression could indicate a unique requirement for myosin contractility in 
the ventral epidermal cells, and although the migratory defects of the ventral epidermal 
cells are rescued, it would be interesting to determine if they migrate with the same 
velocity as wt cells. Loss of MEL-11 causes higher levels of myosin contractility and 
rupture of the embryo likely due to hyper-contraction of the epidermal cells and increased 
tension across cells (Wissmann et al., 1997; Wissmann et al., 1999; Piekny et al., 2000; 
Piekny et al., 2003; Diogon et al., 2007; Gally et al., 2009).  
 
In conclusion, this work helps shed light on how tissues form in vivo. Cell shape 
changes and migration are regulated by the actin-myosin cytoskeleton, and are crucial for 
the development of all metazoans. Furthermore, similar events drive metastasis and the 
advancement of cancers. This thesis describes a novel role for C. elegans anillin (ani-1) 
in the non-autonomous regulation of ventral enclosure, which is a key step in the 
formation of epidermal tissue during C. elegans development. ANI-1 is highly expressed 
in dividing neuroblasts and since anillin regulates cytokinesis in other metazoans, ani-1 
depletion could decrease the number of neuroblasts and impede the migration of 
overlying ventral epidermal cells. My data supports a mechanical model for regulating 
cell migration in vivo, which could improve our understanding of metazoan tissue 
formation. Furthermore, anillin is over-expressed in cancerous tumors in comparison to 
healthy tissues (Hall et al. 2005). Although anillin is likely upregulated to maintain the 
high proliferation rate of cancer cells, it also may be increased to promote higher cell 
























Figure 16. ani-1 RNAi embryonic lethality is enhanced by mutations in genes that 
regulate myosin contractility. Graphs shows the percent hatching for two sets of ani-1 
RNAi experiments for different mutant alleles of genes in the rho-1/elongation pathway. 
Chi-square tests were used to determine statistical significance. A) Shows hatching rates 
(blue) and Lpy Dpy larva (red) of rho-1 (ok2418)/+ with or without ani-1 RNAi, The 
asterix indicates p < 0.05. B) Shows hatching rates (blue), Lpy Dpy larva (red) and Mlc-4 
larva (green) of mlc-4 (or253)/qCI with or without ani-1 RNAi, The asterix indicates p < 
0.05.  C) Shows hatching rates (blue) and Lpy Dpy larva (red) of nmy-1 (sb115) with or 
without ani-1 RNAi, The asterix indicates p < 0.01. D) Shows hatching rates (blue) and 
Lpy Dpy larva (red) of rhgf-2 (sb100) with or without ani-1 RNAi, The asterix indicates 
p < 0.05. E) Shows hatching rates (blue) and Lpy Dpy larva (red) of let-502 (sb118) with 
or without ani-1 RNAi, The asterix indicates p < 0.05. F) Shows hatching rates (blue) and 
Lpy Dpy larva (red) of mel-11 (it26) with or without ani-1 RNAi, The asterix indicates p 
< 0.05 G) Shows hatching rates (blue) and Lpy Dpy larva (red) of let-502 (sb118); mel-





Abmayr, S. M. and Pavlath, G. K. Myoblast fusion: lessons from flies and mice. 
Development. 2012, 139: 641-56.  
 
Ahuja, R., Pinyol, R., Reichenbach, N., Custer, L., Klingensmith, J., Kessels, M. M. and 
Qualmann, B. Cordon-bleu is an actin nucleation factor and controls neuronal 
morphology. Cell. 2007, 131: 337-350.  
 
Alberts, A. S. Identification of a carboxyl-terminal diaphanous-related formin 
homology protein autoregulatory domain. J. Biol. Chem. 2001, 276: 2824-2830. 
 
Amano, M., Ito, M., Kimura, K., Fukata, Y., Chihara, K., Nakano, T., Matsuura, Y. and 
Kaibuchi, K. Phosphorylation and activation of myosin by Rho-associated kinase 
(Rho-kinase). J. Biol. Chem. 1996, 271: 20246-20249. 
 
Anderson, D. C., Gill, J. S., Cinalli, R. M. and Nance, J. Polarization of the C. elegans 
embryo by RhoGAP-mediated exclusion of PAR-6 from cell contacts. Science. 2008, 
320: 1771-1774. 
 
Baum, B. and Georgiou, M. Dynamics of adherens junctions in epithelial 
establishment, maintenance, and remodeling. J. Cell Biol. 2011, 192: 907-917. 
80 
 
Bement, W. M., Forscher, P. and Mooseker, M. S. A novel cytoskeletal structure 
involved in purse string wound closure and cell polarity maintenance. J. Cell Biol. 
1993, 121: 565-78. 
Bement, W. M., Benink, H. A. and von Dassow, G. A microtubule-dependent zone of 
active RhoA during cleavage plane specification. J. Cell Biol. 2005, 170: 91-101. 
Bompard, G., Sharp, S. J., Freiss, G. and Machesky, L. M. Involvement of Rac in actin 
cytoskeleton rearrangements induced by MIM-B. J. Cell Sci. 2005, 118: 5393-5403. 
Bray, D. and White, J. G. Cortical flow in animal cells. Science. 1988, 239: 883-888. 
 
Brenner. S. The genetics of Caenorhabditis elegans. Genetics. 1974, 77: 71-94. 
 
Chin-Sang, I. D., George, S. E., Ding, M., Moseley, S. L., Lynch, A. S. and Chisholm, A. 
D. The ephrin VAB-2/EFN-1 functions in neuronal signaling to regulate epidermal 
morphogenesis in C.elegans. Cell. 1999, 99: 781-790. 
 
Chin-Sang, I. D. and Chisholm A. D. Form of the worm: genetics of epidermal 
morphogenesis in C.elegans. Trends Genet. 2000, 16: 544-551. 
 
Chin-Sang, I. D., Moseley, S. L., Ding, M., Harrington, R. J., George, S. E. and 
Chisholm, A. D. The divergent C. elegans ephrin EFN-4 functions in embryonic 
morphogenesis in a pathway independent of the VAB-1 Eph receptor. Development. 




C.elegans Sequencing Consortium. Genome sequence of the nematode C. elegans: a 
platform for investigating biology. Science. 1998, 282: 2012-2018. 
 
Chisholm, A. D. and Hardin, J. Epidermal morphogenesis. WormBook. 2005, the 
online review of C. elegans biology: 1-22. 
 
Costa, M., Raich, W., Agbunag, C., Leung, B., Hardin, J. and Priess, J. R. A putative 
catenincadherin system mediates morphogenesis of the Caenorhabiditis elegans 
embryo. J. Cell Biol. 1998, 141: 297-308. 
 
Craig, R., Smith, R. and Kendrick-Jones, J. Light-chain phosphorylation controls the 
conformation of vertebrate non-muscle and smooth muscle myosin molecules. 
Nature. 1983, 302: 436-439.  
Curran, S. P., Wu, X., Riedel, C. G. and Ruvkun, G. A soma-to-germline 
transformation in long-lived Caenorhabditis elegans mutants. Nature. 2009, 459: 
1079-1084. 
D'Avino, P. P., Takeda, T., Capalbo, L., Zhang, W., Lilley, K. S., Laue, E. D. and Glover, 
D. M. Interaction between Anillin and RacGAP50C connects the actomyosin 





Diogon, M., Wissler, F., Quintin, S., Nagamatsu, Y., Sookhareea, S., Landmann, F., 
Hutter, H., Vitale, N. and Labouesse, M. The RhoGAP RGA-2 and LET-502/ROCK 
achieve a balance of actomyosin-dependent forces in C. elegans epidermis to control 
morphogenesis. Development. 2007, 134: 2469-2479. 
 
Dorn, J. F., Zhang, L., Paradis, V., Edoh-Bedi, D., Jusu, S., Maddox, P. S. and Maddox, 
A. S. Actomyosin tube formation in polar body cytokinesis requires Anillin in C. 
elegans. Curr. Biol. 2010, 20: 2046-2051. 
 
Dvorsky, R. and Ahmadian, M. R. Always look on the bright site of Rho: structural 
implications for a conserved intermolecular interface. EMBO. 2004, 12: 1130-1136. 
 
Evangelista, M., Pruyne, D., Amberg, D. C., Boone, C. and Bretscher, A. Formins direct 
Arp2/3-independent actin filament assembly to polarize cell growth in yeast. Nat. 
Cell Biol. 2002, 4: 260-269. 
 
Field, C. M. and Alberts, B. M. Anillin, a contractile ring protein that cycles from 
the nucleus to the cell cortex. J. Cell Biol. 1995, 131: 165-178. 
 
Field, C. M., Coughlin, M., Doberstein, S., Marty, T. and Sullivan, W. 
Characterization of anillin mutants reveals essential roles in septin localization and 




Fraser, A. G., Kamath, R. S., Zipperlen, P., Martinez-Campos, M., Sohrmann, M. and 
Ahringer, J. Functional genomic analysis of C. elegans chromosome I by systematic 
RNA interference. Nature. 2000, 408: 325-330. 
Frenette, P., Haines, E., Loloyan, M., Kinal, M., Pakarian, P. and Piekny, A. An anillin-
Ect2 complex stabilizes central spindle microtubules at the cortex during 
cytokinesis. PLoS One. 2012, 7: e34888. 
 
Gally, C., Wissler, F., Zahreddine, H., Quintin, S., Landmann, F. and Labouesse, M. 
Myosin II regulation during C. elegans embryonic elongation: LET-502/ROCK, 
MRCK-1 and PAK-1, three kinases with different roles. Development. 2009, 136: 
3109-3119. 
 
George, S. E., Simokat, K., Hardin, J. and Chisholm, A. D. The VAB-1 Eph receptor 
tyrosine kinase functions in neural and epithelial morphogenesis in C. elegans. Cell. 
1998, 92: 633-643. 
Ghenea, S., Boudreau, J. R., Langue, N. P. and Chin-Sang, I. D. The VAB-1 Eph 
receptor tyrosine kinase and SAX-3/Robo neuronal receptors function together 
during C. elegans embryonic morphogenesis. Development. 2005, 132: 3679-3690. 
 
Glotzer, M. Animal cell cytokinesis. Annu. Rev. Cell Dev. Biol. 2001, 17: 351-86. 
 
Goldbach, P., Wong, R., Beise, N., Sarpal, R., Trimble, W. S. and Brill, J. A. 
84 
 
Stabilization of the actomyosin ring enables spermatocyte cytokinesis in Drosophila. 
Mol. Biol. Cell. 2010, 21: 1482-1493. 
 
Goode, B. L. and Eck, M. J. Mechanism and function of formins in the control of 
actin assembly. Annu. Rev. Biochem. 2007, 76: 593-627.  
 
Gregory, S. L., Ebrahimi, S., Milverton, J., Jones, W. M., Bejsovec, A. and Saint, R. Cell 
division requires a direct link between microtubule-bound RacGAP and Anillin in 
the contractile ring. Curr. Biol. 2008, 18: 25-29.  
 
Hall, A. Rho GTPases and the actin cytoskeleton. Science. 1998, 279: 509-514. 
 
Hall, P. A., Todd, C. B., Hyland, P. L., McDade, S. S., Grabsch, H., Dattani, M., Hillan, 
K. J. and Russell, S. E. The Septin-binding protein anillin is overexpressed in diverse 
human tumors. Clin Cancer Res. 2005, 11: 6780-6786. 
 
Hardin, J., King, R., Thomas-Virnig, C., Raich, W.B. Zygotic loss of ZEN-4/MKLP1 
results in disruption of epidermal morphogenesis in the C. elegans embryo. Dev 
Dyn. 2008, 237: 830-836. 
 
Harrell, J. R. and Goldstein, B. Internalization of multiple cells during C. elegans 
gastrulation depends on common cytoskeletal mechanisms but different cell polarity 




Harrington, R. J., Gutch, M. J., Hengartner, M. O., Tonks, N. K. and Chisholm, A. D. 
The C.elegans LAR-like receptor tyrosine phosphatase PTP-3 and the VAB-1 Eph 
receptor tyrosine kinase have partly redundant functions in morphogenesis. 
Development. 2002, 129: 2141-2153. 
 
Heid, P. J., Raich, W. B., Smith, R., Mohler, M. A., Simokat, K., Gendreau, S. B., 
Rothman, J. H. and Hardin, J. The zinc finger protein DIE-1 is required for late events 
during epithelial cell rearrangement in C. elegans. Dev. Biol. 2001, 236: 165-180. 
 
Hickson, G. R. and O’Farrell, P. H. Rho-dependent control of anillin behavior during 
cytokinesis. J. Cell Biol. 2008, 180: 285-294.  
 
Ikegami, R., Simokat, K., Zheng, H., Brown, L., Garriga, G., Harin, J. and Culotti, J. 
Semaphorin and Eph receptor signaling guide a series of cell movements for ventral 
enclosure in C. elegans. Curr. Biol. 2012, 22: 1-11. 
 
Kamath, R. S., Fraser, A. G., Dong, Y., Poulin, G., Durbin, R., Gotta, M., Kanapin, A., 
Le Bot, N., Moreno, S., Sohrmann, M., Welchman, D. P., Zipperlen, P. and Ahringer, J. 
Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. 




Kawano, Y., Fukata, Y., Oshiro, N., Amano, M., Nakamura, T., Ito, M., Matsumura, F., 
Inagaki, M. and Kaibuchi, K. Phosphorylation of myosin-binding subunit (MBS) of 
myosin phosphatase by Rho-kinase in vivo. J. Cell Biol. 1999, 147: 1023-1038. 
 
Kimura, K., Ito, M., Amano, M., Chihara, K., Fukata, Y., Nakafuku, M., Yamamori, B., 
Feng, J., Nakano, T., Okawa, K., Iwamatsu, A. and Kaibuchi, K. Regulation of myosin 
phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science. 1996, 273: 
245-248. 
 
Kobielak, A. and Fuchs, E. Alpha-catenin: at the junction of intracellular adhesion 
and actin dynamics. Rev. Mol. Cell Biol. 2004, 5: 614-625. 
 
Koppen, M., Simske, J. S., Sims, P. A., Firestein, B. L., Hall, D. H., Radice, A. D., 
Rongo, C. and Hardin, J. D. Cooperative regulation of AJM-1 controls junctional 
integrity in Caenorhabditis elegans epithelia. Nat. Cell Biol. 2001, 3: 983-991. 
 
Kovar, D. R. Molecular details of formin-mediated actin assembly. Curr. Opin. Cell 
Biol. 2006, 18: 11-17.  
 
Kurisu, S. and Takenawa, T. The WASP and WAVE family proteins. Genome Biol. 




Labouesse, M. Epithelial junctions and attachments. WormBook. 2006, online review: 
1-16. 
 
Li, F. and Higgs, H. N. Dissecting requirements for auto-inhibition of actin 
nucleation by the formin, mDia1. J. Biol. Chem. 2005, 280: 6986-6992. 
 
Lin, L., Tran, T., Hu, S., Cramer, T., Komuniecki, R. and Steven, R. M. RHGF-2 is an 
essential Rho-1 specific RhoGEF that binds to the multi-PDZ domain scaffold 
protein MPZ-1 in Caenorhabditis elegans. PLoS One. 2012, 7: e31499. 
 
Machesky, L. M. and Insall, R. H. Scar1 and the related Wiskott–Aldrich syndrome 
protein, WASP, regulate the actin cytoskeleton through the Arp2/3 complex.  
Curr. Biol. 1998, 8: 1347-56. 
 
Mackay, D. J., Nobes, C. D. and Hall, A. The Rho’s progress: a potential role during 
neuritogenesis for the Rho family of GTPases. Trends Neurosci. 1995, 18: 496-501. 
 
Maddox, A. S., Habermann, B., Desai, A. and Oegema, K. Distinct roles for two C. 
elegans anillins in the gonad and early embryo. Development. 2005, 132: 2837-2848. 
 
Maddox, A. S., Lewellyn, L., Desai, A. and Oegema, K. Anillin and the septins 





Mains, P. E., Kemphues, K. J., Sprunger, S. A., Sulston, I. A. and Wood, W. B. 
Mutations affecting the meiotic and mitotic divisions of the early Caenorhabditis 
elegans embryo. Genetics. 1990, 126: 593-605. 
 
Matsumura, F. Regulation of myosin II during cytokinesis in higher eukaryotes. 
Trends Cell Biol. 2005, 15: 371-377. 
 
Mullins, R. D., Heuser, J. A. and Pollard T. D. The interaction of Arp2y3 complex with 
actin: Nucleation, high affinity pointed end capping, and formation of branching 
networks of filaments. Proc Natl Aca Sci. 1998, 95: 6181-6186. 
 
Nance, J., Lee J. Y. and Goldstein, B. Gastrulation in C.elegans. WormBook. 2005, 
online review: 1-13. 
 
Oegema, K., Savoian, M. S., Mitchison, T. J. and Field, C. M. Functional analysis of a 
human homologue of the Drosophila actin binding protein anillin suggests a role in 
cytokinesis. J. Cell Biol. 2000, 150: 539-552.  
 
Patel, F. B., Bernadskaya, Y. Y., Chen, E., Jobanputra, A., Pooladi, Z., Freeman, K. L., 
Gally, C., Mohler, W.A. and Soto, M. C. The WAVE/SCAR complex promotes 
polarized cell movements and actin enrichment in epithelia during C. elegans 




Paul, A. D. and Pollard, T. D. Review of the mechanism of processive actin filament 
elongation by formins. Cell Motil. Cytoskeleton. 2009, 66: 606-617.  
 
Pestonjamasop, K. N., Forster, C., Sun, C., Gardiner, E. M., Bohl, B., Weiner, O., 
Bokock, G. M. and Glogauer, M. Rac1 links leading edge and uropod events through 
Rho and myosin activation during chemotaxis. Blood. 2006, 108: 2814-2820.  
 
Pettitt, J., Cox, E. A., Broadbent, I. D., Flett, A. and Hardin, J. The Caenorhabditis 
elegans p120 catenin homologue, JAC-1, modulates cadherin-catenin function 
during epidermal morphogenesis. J. Cell Biol. 2003, 162: 15-22. 
 
Piekny, A. J., Wissmann, A. and Mains, P. E. Embryonic morphogenesis in 
Caenorhabditis elegans integrates the activity of LET-502 Rho-binding kinase, 
MEL-11 myosin phosphatase, DAF-2 insulin receptor and FEM-2 PP2c 
phosphatase. Genetics. 2000, 156: 1671-1689. 
 
Piekny, A. J. and Mains, P. E. Rho-binding kinase (LET-502) and myosin 
phosphatase (MEL-11) regulate cytokinesis in the early Caenorhabditis elegans 
embryo. J. Cell Sci. 2002, 115: 2271-2282. 
 
Piekny, A. J., Johnson, J. L., Cham, G. D. and Mains, P. E. The Caenorhabditis elegans 
nonmuscle myosin genes nmy-1 and nmy-2 function as redundant components of the 
90 
 
let-502/Rho-binding kinase and mel-11/myosin phosphatase pathway during 
embryonic morphogenesis. Development. 2003, 130: 5695-5704.  
 
Piekny, A. J. and Mains, P. E. Squeezing an egg into a worm: C. elegans embryonic 
morphogenesis. SWJ. 2003, 3: 1370-1381. 
 
Piekny, A. J., Werner, M. and Glotzer, M. Cytokinesis: welcome to the Rho zone. 
Trends Cell Biol. 2005, 15: 651-658. 
 
Piekny, A. J. and Glotzer, M. Anillin is a scaffold protein that links RhoA, actin and 
myosin during cytokinesis. Curr. Biol. 2008, 18: 30-36. 
 
Piekny, A. J. and Maddox, A. S. The myriad roles of Anillin during cytokinesis. Sem. 
Cell Dev. Biol. 2010, 21: 881-891. 
 
Pollard, T. D., Blanchoi, L. and Mullins, R. D. Molecular mechanisms controlling 
actin filaments dynamics in nonmuscle cells.  Annu. Rev. Biophys. Biomol. Struct. 
2000, 29: 545-576.  
 
Pollard, T. D. and Cooper, J. A. Actin, a central player in cell shape and movement. 
Science. 2009, 326: 1208-1212. 
 
Priess, J. R. and Hirsh, D. I. Caenorhabditis elegans morphogenesis: the role of the 
91 
 
cytoskeleton in elongation of the embryo. Dev. Biol. 1986, 117: 156-173. 
 
Quinn, C. C., Pfeil, D. S. and Wadsworth, W. G. CED-10/Rac1 mediates axon 
guidance by regulating the asymmetric distribution of MIG-10/lamellipodin. Curr. 
Biol. 2008, 18: 808-813. 
 
Raich, W. B., Agbunag, C. and Hardin, J. Rapid epithelial-sheet sealing in the 
Caenorhabditis elegans embryo requires cadherin-dependent filopodial priming. 
Curr. Biol. 1999, 9: 1139-1146. 
 
Ridley, A. J., Paterson, H. F., Johnston, C. L., Diekmann, D. and Hall, A. The small 
GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell. 
1992, 70: 401-410. 
 
Roh-Johnson, M., Shemer, G., Higgins, C. D., McClellan, J. H., Werts, A. D., Tulu, U. 
S., Gao, L., Betzig, E., Kiehart, D. P. and Goldstein, B. Triggering a cell shape change 
by exploiting preexisting actomyosin contractions. Science. 2012, 335: 1232-1235. 
 
Rossman, K. L., Der, C. J. and Sondek, J. GEF means go: turning on RHO GTPases 
with guanine nucleotide-exchange factors. Nat. Rev. Mol. Cell Biol. 2005, 6: 167-180.  
 
Sawa, M., Suetsguru, S., Sugimoto, A., Miki, H., Yamamoto, M. and Takenawa, T. 
Essential role of the C. elegans Arp2/3 complex in cell migration during ventral 
92 
 
enclosure. J. Cell Sci. 2003, 116: 1505-1518.  
 
Simske, J. S. and Hardin, J. Getting into shape: epidermal morphogenesis in 
Caenorhabditis elegans embryos. Bioessays. 2001, 23: 12-23. 
 
Somers, W. G. and Saint, R. A RhoGEF and Rho family GTPase-activating protein 
complex links the contractile ring to cortical microtubules at the onset of 
cytokinesis. Dev. Cell. 2003, 4: 29-39. 
 
Somlyo, A. P. and Somlyo, A. V. Signal transduction by G-proteins, rho-kinase and 
protein phosphatase to smooth muscle and non-muscle myosin II. J. Phys. 2000, 522: 
177-185. 
 
Soto, M. C., Qadota, H., Kasuya, K., Inoue, M., Tsuboi, D., Mello, C. C. and Kaibuchi, 
K. The GEX-2 and GEX-3 proteins are required for tissue morphogenesis and cell 
migrations in C. elegans. Genes Dev. 2002, 16: 620-632. 
 
Straight, A. F., Field, C. M. and Michitson, T. J. Anillin binds Nonmuscle myosin II 
and regulates the contractile ring. Mol. Biol. Cell. 2005, 16: 193-201.  
 
Sulston, J. E and Horvitz, H. R. Post-embryonic cell lineages of the nematode, 




Sulston, J. E., Schierenberg, E., White, J. G. and Thomson, J. N. The embryonic cell 
lineage of the nematode Caenorhabditis elegans. Dev. Biol. 1983, 100: 64-119.  
 
Swan, K. A., Severson, A. F., Carter, C. J., Martin, P. R., Schnabel, H., Schnabel, R. and 
Bowerman, B. cyk-1: a C. elegans FH gene required for a late step in embryonic 
cytokinesis. J. Cell Sci. 1998, 111: 2017-2027. 
 
Symons, M., Derry, J. M., Karlak, B., Jiang, S., Lemahieu, V., Mccormick, F., Francke, 
U. and Abo, A. Wiskott-Aldrich syndrome protein, a novel effector for the GTPase 
CDC42Hs, is implicated in actin polymerization. Cell. 1996, 84: 723-734. 
 
Tapon, N. and Hall, A. Rho, Rac and Cdc42 GTPases regulate the organization of the 
actin cytoskeleton. Curr. Opin. Cell Biol. 1997, 9: 86-92. 
 
Torres, E., Rosen, M. K. Protein-tyrosine Kinase and GTPase Signals Cooperate to 
Phosphorylate and Activate Wiskott-Aldrich Syndrome Protein (WASP)/Neuronal 
WASP. J. Biol Chem. 2006, 281: 3513-3520.  
 
Totsukawa, G., Yamakita, Y., Yamashiro, S., Hartshorne, D. J., Sasaki, Y. and 
Matsumuta, F. Distinct roles of ROCK (Rho-kinase) and MLCK in spatial regulation 
of MLC phosphorylation for assembly of stress fibers and focal adhesions in 3T3 




Tse, Y. C., Piekny, A. J. and Glotzer, M. Anillin promotes astral microtubule-directed 
cortical myosin polarization. Mol. Biol. Cell. 2011, 22: 3165-3175.  
 
Vicente-Manzanares, M., Ma, X., Adelstein, R. S. and Horwitz A. R. Non-muscle 
myosin II takes centre stage in cell adhesion and migration. Nat. Rev. Mol. Cell Biol. 
2009, 10: 778-790. 
 
Wang, X., Roy, P. J., Holland, S. J., Zhang, L. W., Culotti, J. G. and Pawson, T. Multiple 
Ephrins Control Cell Organization in C. elegans Using Kinase-Dependent and -
Independent Functions of the VAB-1 Eph Receptor.  Mol. Cell. 1999, 4: 903-913.  
 
Welch, M. D., DePace, A. H., Verma, S., Iwamatsu, A. and Mitchison, T. J. The human 
Arp2/3 complex is composed of evolutionarily conserved subunits and is localized to 
cellular regions of dynamic actin filament assembly. J. Cell Biol. 1997, 138: 375-384. 
 
Williams-Masson, E. M., Malik, A. N. and Hardin, J. An actin-mediated two-step 
mechanism is required for ventral enclosure of the C. elegans hypodermis. 
Development. 1997, 124: 2889-2901. 
 
Williams-Masson, E. M., Heid, P. J., Lavin, C. A. and Hardin, J. The cellular 
mechanism of epithelial rearrangement during morphogenesis of the 




Wissmann, A., Ingles, J., McGhee, J. D. and Mains, P. E. Caenorhabditis elegans LET-
502 is related to Rho-binding kinases and human myotonic dystrophy kinase and 
interacts genetically with a homolog of the regulatory subunit of smooth muscle 
myosin phosphatase to affect cell shape. Genes Dev. 1997, 11: 409-422. 
 
Wissmann, A., Ingles, J. and Mains, P. E. The Caenorhabditis elegans mel-11 myosin 
phosphatase regulatory subunit affects tissue contraction in the somatic gonad and 
the embryonic epidermis and genetically interacts with the Rac signaling pathway.  
Dev. Biol. 1999, 209: 111-127. 
 
Withee, J., Galligan, B., Hawkins, N. and Garriga, G. Caenorhabditis elegans WASP 
and Ena/VASP proteins play compensatory roles in morphogenesis and neuronal 
cell migration. Genetics. 2004, 167: 1165-1176. 
 
Yamashiro, S., Totsukawa, G., Yamakita, Y., Sasaki, Y., Madaule, P., Ishizaki, T., 
Narumiya, S. and Matsumura, F. Citron kinase, a Rho-dependent kinase, induces di-
phosphorylation of regulatory light chain of myosin II. Mol. Biol. Cell. 2003, 14: 
1745-1756. 
 
Yasui, Y., Amano, M., Nagata, K., Inagaki, N., Nakamura, H., Sava, H., Kaibuchi, K. 
and Inagaki, M. Roles of Rho-associated Kinase in Cytokinesis; Mutations in Rho-
96 
 
associated Kinase Phosphorylation Sites Impair Cytokinetic Segregation of Glial 
Filaments. JCB. 1998, 143: 1249-1258  
 
Yuce, O., Piekny, A. and Glotzer, M. An ECT2-centralspindlin complex regulates 
localization and function of RhoA. J. Cell Biol. 2005, 170: 571-582. 
 
Zhang, H., Gally, C., Labouesse, M. Tissue morphogenesis: how multiple cells 
cooperate to generate a tissue. Curr. Opin. Cell Biol. 2010, 22: 575-582. 
 
Zhang, L. and Maddox, A. S. Anillin. Curr. Biol. 2010, 20: 135-136. 
 
aZhao, W. M. and Fang, G. Anillin is a substrate of anaphase-promoting 
complex/cyclosome (APC/C) that controls spatial contractility of myosin during late 
cytokinesis. J. Biol. Chem. 2005, 280: 33516-33524. 
 
bZhao, W. M and Fang, G. MgcRacGap controls the assembly of the contractile ring 
and the initiation of cytokinesis. Proc. Natl. Sci. USA. 2005, 102: 13158-13163.  
 
 
 
 
 
 
 
